Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionCardinal Capital Management
Latest Disclosed Ownership46,693 shares
Latest Disclosed Value $ 1,772,128
Cardinal Capital Management reports 3.05% increase in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On April 8, 2026 - Cardinal Capital Management filed a 13F-HR form disclosing ownership of 46,693 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $1,473,164 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 45,310 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 3.05% during the quarter. The current value of the position is $1,672,543 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 46,693 1,383 3.05 1,772 -23.12 0.2285
2026-01-30 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 45,310 -5,318 -10.50 2,305 -17.94 0.3053
2025-10-23 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 50,628 1,052 2.12 2,809 -17.89 0.3883
2025-07-15 2025-06-30 13F NOVO-NORDISK A S Common Stock 670100205 49,576 1,161 2.40 3,422 0.15 0.5022
2025-04-18 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 48,415 14 0.03 3,417 -17.94 0.5291
2025-01-31 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 48,401 143 0.30 4,163 -27.55 0.6529
2024-10-16 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 48,258 -54 -0.11 5,746 -16.68 0.8939
2024-07-12 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 48,312 -20,417 -29.71 6,896 -22.39 1.1615
2024-07-12 2024-03-31 13F/A-1 NOVO-NORDISK A S ADR 670100205 68,729 1,422 2.11 8,887 27.64 1.4460
2024-04-15 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 68,729 1,422 8,887 1.4460
2024-07-12 2023-12-31 13F/A-1 NOVO-NORDISK A S ADR 670100205 67,307 -772 -1.13 6,963 12.45 1.3185
2024-01-29 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 67,307 -772 6,963 1.3185
2024-07-12 2023-09-30 13F/A-1 NOVO-NORDISK A S ADR 670100205 68,079 34,166 100.75 6,191 12.81 1.2603
2023-10-16 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 68,079 34,166 6,191 1.2603
2024-07-12 2023-06-30 13F/A-1 NOVO-NORDISK A S ADR 670100205 33,913 -536 -1.56 5,488 -0.62 1.1052
2023-07-12 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 33,913 -536 5,488 1.1052
2023-04-19 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 34,449 -394 -1.13 5,523 17.12 1.1459
2023-01-23 2022-12-31 13F Novo Nordisk A S ADR ADR 670100205 34,843 -532 -1.50 4,716 33.80 1.0038
2022-10-24 2022-09-30 13F Novo Nordisk A S ADR ADR 670100205 35,375 -589 -1.64 3,524 -12.05 0.8340
2022-08-04 2022-06-30 13F Novo Nordisk A S ADR ADR 670100205 35,964 64 0.18 4,007 0.50 0.9169
2022-04-21 2022-03-31 13F Novo Nordisk A S ADR ADR 670100205 35,900 728 2.07 3,987 1.22 0.8065
2022-01-18 2021-12-31 13F Novo Nordisk A S ADR ADR 670100205 35,172 -224 -0.63 3,939 15.92 0.7801
2021-10-21 2021-09-30 13F Novo Nordisk A S ADR ADR 670100205 35,396 -231 -0.65 3,398 13.87 0.7357
2021-07-14 2021-06-30 13F Novo Nordisk A S ADR ADR 670100205 35,627 256 0.72 2,984 25.12 0.6300
2021-04-19 2021-03-31 13F Novo Nordisk A S ADR ADR 670100205 35,371 351 1.00 2,385 -2.49 0.5259
2021-02-01 2020-12-31 13F Novo Nordisk A S ADR ADR 670100205 35,020 481 1.39 2,446 2.00 0.5791
2020-10-16 2020-09-30 13F Novo Nordisk A S ADR ADR 670100205 34,539 66 0.19 2,398 6.25 0.6607
2020-07-16 2020-06-30 13F Novo Nordisk A S ADR ADR 670100205 34,473 -5,369 -13.48 2,257 -5.88 0.6494
2020-04-20 2020-03-31 13F Novo Nordisk A S ADR ADR 670100205 39,842 -513 -1.27 2,398 2.65 0.7920
2020-01-21 2019-12-31 13F Novo Nordisk A S ADR ADR 670100205 40,355 -305 -0.75 2,336 11.13 0.6066
2019-10-18 2019-09-30 13F Novo Nordisk A S ADR ADR 670100205 40,660 45 0.11 2,102 1.40 0.5806
2019-07-08 2019-06-30 13F Novo Nordisk A S ADR ADR 670100205 40,615 -677 -1.64 2,073 -3.98 0.5883
2019-04-11 2019-03-31 13F Novo Nordisk A S ADR ADR 670100205 41,292 236 0.57 2,159 14.17 0.6169
2019-01-15 2018-12-31 13F Novo Nordisk A S ADR ADR 670100205 41,056 788 1.96 1,891 -0.37 0.6233
2018-10-25 2018-09-30 13F Novo Nordisk A S ADR ADR 670100205 40,268 200 0.50 1,898 2.71 0.5371
2018-07-25 2018-06-30 13F Novo Nordisk A S ADR ADR 670100205 40,068 675 1.71 1,848 -4.74 0.5594
2018-04-24 2018-03-31 13F Novo Nordisk A S ADR ADR 670100205 39,393 200 0.51 1,940 -7.75 0.6095
2018-02-01 2017-12-31 13F Novo Nordisk A S ADR ADR 670100205 39,193 274 0.70 2,103 12.28 0.6364
2017-10-24 2017-09-30 13F Novo Nordisk A S ADR ADR 670100205 38,919 3,876 11.06 1,873 24.62 0.5913
2017-07-27 2017-06-30 13F Novo Nordisk A S ADR ADR 670100205 35,043 7,493 27.20 1,503 59.22 0.4969
2017-04-25 2017-03-31 13F Novo Nordisk A S ADR ADR 670100205 27,550 0 0.00 944 -4.45 0.3416
2017-02-17 2016-12-31 13F/A-1 Novo Nordisk A S ADR ADR 670100205 27,550 27,550 988 0.3762
2017-01-23 2016-12-31 13F Novo Nordisk A S ADR ADR 670100205 27,550 988
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.